Acta Pharmacologica Sinica : Impact Factor & More
eISSN: 1745-7254pISSN: 1671-4083
Share this on:
Key Metrics
CiteScore 
11.3
Eigenfactor
0.005 - 0.01
H-Index
108
Impact Factor
5 - 10
SJR
Q1Pharmacology
SNIP
1.62
Recommended pre-submission checks
Powered by 
Run standard language and technical checks to improve your manuscript – before you submit
Technical Compliance
Ensure manuscript complies with standard submission guidelines.
Language Quality
Improve clarity, grammar, and academic writing style.
A comprehensive report covering all these checks awaits you.
Topics Covered on Acta Pharmacologica Sinica
Acta Pharmacologica Sinica Journal Specifications
| Overview | |
| Publisher | NATURE PUBL GROUP |
| Language | English |
| Frequency | Monthly |
| General Details | |
| Language | English |
| Frequency | Monthly |
| Publication Start Year | 1980 |
| Publisher URL | Visit website |
| Website URL | Visit website |
View less
Planning to publish in Acta Pharmacologica Sinica ?
Upload your Manuscript to get
- Degree of match
- Common matching concepts
- Additional journal recommendations
Recently Published Papers in Acta Pharmacologica Sinica
Gut microbiota modulation of gastrointestinal cancers: from dysbiosis signatures to therapeutic interventions.
- 6 Aug 2026
- Acta pharmacologica Sinica
Smoothened signaling in microglia: canonical or not, and does it promote or limit inflammation?
- 5 Aug 2026
- Acta pharmacologica Sinica
PGK1-driven histone lactylation fuels MDSC-driven immune evasion and tumor progression in triple-negative breast cancer.
- 4 Aug 2026
- Acta pharmacologica Sinica
Beyond conventional therapies: the evolution of targeted agents and immunotherapies in triple-negative breast cancer.
- 4 Aug 2026
- Acta pharmacologica Sinica
Secreted chimeric proteins as a strategy to correct SOX17 deficiency and attenuate the malignant phenotype of cholangiocarcinoma cells: a proof-of-concept study.
- 4 Aug 2026
- Acta pharmacologica Sinica
MiR-203 improves pressure overload-induced heart failure by targeting the IGFBP5/PI3K/AKT axis.
- 4 Aug 2026
- Acta pharmacologica Sinica
Gut microbiota modulation of gastrointestinal cancers: from dysbiosis signatures to therapeutic interventions.
- 6 Aug 2026
- Acta pharmacologica Sinica
Smoothened signaling in microglia: canonical or not, and does it promote or limit inflammation?
- 5 Aug 2026
- Acta pharmacologica Sinica
PGK1-driven histone lactylation fuels MDSC-driven immune evasion and tumor progression in triple-negative breast cancer.
- 4 Aug 2026
- Acta pharmacologica Sinica
Beyond conventional therapies: the evolution of targeted agents and immunotherapies in triple-negative breast cancer.
- 4 Aug 2026
- Acta pharmacologica Sinica
Secreted chimeric proteins as a strategy to correct SOX17 deficiency and attenuate the malignant phenotype of cholangiocarcinoma cells: a proof-of-concept study.
- 4 Aug 2026
- Acta pharmacologica Sinica
MiR-203 improves pressure overload-induced heart failure by targeting the IGFBP5/PI3K/AKT axis.
- 4 Aug 2026
- Acta pharmacologica Sinica
FAQs on Acta Pharmacologica Sinica
How long has Acta Pharmacologica Sinica been actively publishing? 
What is the publishing frequency of Acta Pharmacologica Sinica?
How many articles did Acta Pharmacologica Sinica publish last year?
What is the eISSN & pISSN for Acta Pharmacologica Sinica?
What is Citescore for Acta Pharmacologica Sinica?
What is the H Index for Acta Pharmacologica Sinica ?
What is SNIP score for Acta Pharmacologica Sinica?
What is the SJR for Acta Pharmacologica Sinica?
Who is the publisher of Acta Pharmacologica Sinica?
